“From Dock to Doc”: Spotlite360 Announces Blockchain and IoT Solution for Healthcare Industry Supply Chains

DENVER and VANCOUVER, British Columbia, July 12, 2021 (GLOBE NEWSWIRE) -- SPOTLITE360 TECHNOLOGIES, INC. (“Spotlite360” or the “Company”) (CSE: LITE) is pleased to announce that it has begun to commercialize its enterprise software solution in the healthcare industry to help overcome many of the common challenges in healthcare supply chains. In a press release dated July 6, 2021 the Company announced its pharmaceutical industry initiative to provide tracking, tracing, and sustainability solutions for stakeholders in the sourcing, production, transportation, and distribution of medications. With several operational and compliance nuances that are unique to healthcare supply chains, Spotlite360 has tailored its software solution which leverages blockchain, Internet-of-Things (“IoT”) sensors, and machine learning to align with the current and future requirements of healthcare firms across North America. The Company has started introducing this solution to prospective accounts in the healthcare industry.

Recent events in the healthcare industry have highlighted several weak points in supply chains which could stand to be remedied by the Spotlite360 technologies. Global shortages in product categories such as personal protective equipment, concerns surrounding the authenticity of goods, and greater pressure to deliver orders with short lead times have created unfavourable situations for many firms in the healthcare industry. In the case of the latter, predatory healthcare supplier practices were an emerging problem in early 2020 as noted in a March 27, 2020 bulletin from the Federal Bureau of Investigation1. Because many of these practices sought to exploit “blind spots” in the supply chain (e.g., claiming that a shipment was delayed due to customs difficulties), purchasers had limited recourse in the absence of end-to-end supply chain visibility.

The Spotlite360 technologies capture real-time and event-driven data through IoT and RFID sensors, which allow for healthcare firms to realize benefits that could include the following:

  • Comprehensive visibility of the supply chain from point of origin to the end user in a healthcare setting (e.g., hospital, clinic);
  • Detection of tampering, theft, loss, and damage to protect the supply chain’s integrity and prevent waste;
  • Promote accountability among suppliers, distributors, and logistics partners; and
  • Limit providers’ liability by taking a proactive and diligent approach to monitoring all relevant assets in their journey through the supply chain.

Spotlite360 President James Greenwell commented, “We have identified healthcare as one area in which Spotlite360’s technologies can make a considerable difference at each step in the supply chain. Healthcare firms are accountable to their patients, employees, regulators, and any dependent partners or suppliers, with increasingly high standards in areas such as visibility and reporting. Spotlite360’s ability to consolidate a variety of tracking methods throughout a supply chain while leveraging technologies such as blockchain and machine learning can provide significant value to clients in healthcare, and we look forward to bringing these benefits to the industry as we kick off our commercialization efforts to begin gaining market share in 2021.”

Sources

1 - https://www.fbi.gov/news/pressrel/press-releases/fbi-warns-health-care-professionals-of-increased-potential-for-fraudulent-sales-of-covid-19-related-medical-equipment

On behalf of the Board of Directors of the Company,

Spotlite360 Technologies Inc.

“James Greenwell”

James Greenwell, President

For more information about Spotlite360, please visit: http://spotlite360.com

Charles Lee
Investor Relations and Media Inquiries
+1 (720) 830-6120
ir@spotlite360.com

THE CANADIAN SECURITIES EXCHANGE (“CSE”) HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE, NOR HAS OR DOES THE CSE’S REGULATION SERVICES PROVIDER.

About Spotlite360 Technologies Inc.

Spotlite360 is a logistics technologies solutions provider unlocking value, opportunities, and efficiencies for all participants in a supply chain. Building upon existing applications of IoT technologies, distributed ledgers, and machine learning, Spotlite360 endeavours to set new standards of transparency, integrity, and sustainability in the pharmaceutical, healthcare, and agriculture industries. As regulators across the globe begin to impose new tracing and accountability requirements for the protection of consumers (e.g., DSCSA and FSMA from the U.S. Food and Drug Administration), the need for reliable, cost-effective, and versatile tracking technology is expected to grow considerably. Spotlite360’s flagship SaaS solution has been engineered to seamlessly track the movement of a product by integrating with systems of all major stakeholders in a supply chain ranging from the raw materials to the hands of the end consumer. With a primary objective of onboarding new clients in 2021, Spotlite360 plans to explore innovative use cases for its proprietary stack of technologies which could transform logistics workflows in some of the world’s largest industries.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable Canadian securities legislation, with respect to the Company. The forward-looking information included in this news release is not based on historical facts, but rather on the expectations of the Company’s management regarding the future growth of the Resulting Issuer, its results of operations, performance, business prospects, and opportunities. This news release uses words such as “will”, “expects”, “anticipates”, “intends”, “plans”, “believes”, “estimates”, or similar expressions to identify forward-looking information. Such forward-looking information reflects the current beliefs of the Company’s management, based on information currently available to them.

This forward-looking information includes, among other things, statements relating to: the intentions, plans and future actions of the Company; statements relating to the business and future activities of the Company; anticipated developments in operations of the Company; market position, ability to compete, and future financial or operating performance of the Company; the timing and amount of funding required to execute the business plans of the Company; capital expenditures of the Company; the effect on the Company, of any changes to existing or new legislation or policy or government regulation; the length of time required to obtain permits, certifications and approvals; the availability of labour; estimated budgets; currency fluctuations; requirements for additional capital; limitations on insurance coverage; the timing and possible outcome of regulatory and permitting matters; goals; strategies; future growth; the adequacy of financial resources; our expectations regarding revenues, expenses and anticipated cash needs.

In addition, any statements that refer to expectations, intentions, projections or other characterizations of future events or circumstances contain forward-looking information. Forward-looking statements are based on certain assumptions and analyses made by the Company in light of the experience and perception of historical trends, current conditions, and expected future developments and other factors it believes are appropriate, and are subject to risks and uncertainties. Although the Company believes that the assumptions underlying these statements are reasonable, they may prove to be incorrect, and there can be no assurance that actual results will be consistent with these forward-looking statements. Given these risks, uncertainties, and assumptions, prospective investors should not place undue reliance on these forward-looking statements. Whether actual results, performance, or achievements will conform to the expectations and predictions of the Company is subject to a number of known and unknown risks, uncertainties, assumptions, and other factors, including those listed in the Company's non-offering prospectus dated May 26, 2021.

If any of these risks or uncertainties materialize, or if assumptions underlying the forward-looking statements prove incorrect, actual results might vary materially from those anticipated in the forward-looking statements. Information contained in forward-looking statements in this news release is provided as of the date of this news release, and the Company disclaims any obligation to update any forward-looking statements, whether as a result of new information or future events or results, except to the extent required by applicable securities laws. Accordingly, potential investors should not place undue reliance on forward-looking statements or the information contained in those statements.

All of the forward-looking information contained in this news release is expressly qualified by the foregoing cautionary statements.

Statement Regarding Third-Party Investor Relations Firms

Disclosures relating to investor relations firms retained by Spotlite360 Technologies Inc. can be found under the Company's profile on http://sedar.com.


Image: Primary Logo

Source: Spotlite360 Technologies Inc.

News, commentary and research reports are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.